Motley Fool • yesterday
President-elect Donald Trump took aim at drug developers in a recent Time magazine interview and as a result, biopharma stocks are selling off.
Insider Monkey • yesterdayTeva Pharmaceutical Industries Ltd (ADR) (TEVA)’s End-Of-Year Switch Of Generics CEO Surprises Investors
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shareholders were treated to an unpleasant surprise by generics CEO Siggi Olafsson, who is said to be jumping ship. The move has also scared off investors and sent Teva shares south. But apparently, analysts were not puzzled by the news that Olafsson was turning the reins over to Dipankar […]
Barrons.com • yesterday
Piper Jaffray’s David Amsellem and his team take a look at Allergan (AGN) Wednesday, and they aren’t optimistic about the stock’s prospects in 2017. Amesellem writes that data from retail prescription volumes across Allergan’sU.S. commercial portfolio reinforced their concerns about Allergan’s business. As such, he writes that he doesn’t think Allergan is poised for a rebound, and the shares valuation reflect the Street’s overly rosy growth expectations.
CNBC • 2 days ago
Shares of Teva dropped more than 5 percent Tuesday after the company announced the head of its global generic medicine group will step down.
Insider Monkey • 2 days ago
Billionaire John Griffin founded Blue Ridge Capital 20 years ago, after working as Julian Robertson’s number two for years. The “Tiger Cub” is a value-oriented investor who has proven quite successful over time. As per Insider Monkey’s data, Mr. Griffin’s long equity stakes returned an average of 0.76% per month between 1999 and 2012 – […]
TheStreet.com • 3 days ago
Siggi Olfasson is poised to step down as president and CEO of Teva's global generic medicines group by the end the first quarter of 2017.
CNBC Videos • 7 hours ago
Chris Retzler, Needham Growth Fund, and Ronny Gal, Sanford C. Bernstein, discuss buying opportunities amid health care's underperformance. With CNBC's Mike Santoli and Stephanie Link, TIAA Global Asset Management.
AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance
Allergan plc (AGN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||188.00 x 100|
|Ask||188.90 x 400|
|Day's Range||185.70 - 191.00|
|52 Week Range||184.50 - 317.48|
|PE Ratio (TTM)||5.29|
|Earnings Date||Feb 17, 2017|
|Dividend & Yield||2.80 (1.46%)|
|1y Target Est||264.84|